Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract 2854: The potential of hyperpolarized 13-C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents

Ane B. Iversen, Morten Busk, Lotte B. Bertelsen, Christoffer Laustsen, Ole L. Munk, Thomas Nielsen, Thomas R. Wittenborn, Johan Bussink, Jasper Lok, Hans Stodkilde-Jorgensen, Michael R. Horsman

Cancer Res (2017) 77 (13_Supplement): 2854.

https://doi.org/10.1158/1538-7445.AM2017-2854

Published: 01 July 2017

View article titled, Abstract 2854: The potential of hyperpolarized 13-C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents

Journal Articles

Abstract 2001: Preclinical investigation of a 15 gene hypoxia profile in different prostate cancer cell lines

Thomas R. Wittenborn, Brita S. Sorensen, Morten Busk, Mathilde B. Thomsen, Steffen Nielsen, Michael R. Horsman

Cancer Res (2017) 77 (13_Supplement): 2001.

https://doi.org/10.1158/1538-7445.AM2017-2001

Published: 01 July 2017

View article titled, Abstract 2001: Preclinical investigation of a 15 gene hypoxia profile in different prostate cancer cell lines

Journal Articles

Abstract 4498: Assessing the effects of the small molecule cathepsin L inhibitor, KGP94: combination with radiotherapy and evaluation of antimetastatic potential in vivo

Thomas R. Wittenborn, Michael R. Horsman

Cancer Res (2015) 75 (15_Supplement): 4498.

https://doi.org/10.1158/1538-7445.AM2015-4498

Published: 01 August 2015

View article titled, Abstract 4498: Assessing the effects of the small molecule cathepsin L inhibitor, KGP94: combination with radiotherapy and evaluation of antimetastatic potential in vivo

Journal Articles

Abstract 1796: Targeting the microenvironment and vasculature of tumors to improve response to radiation administered using a dose and schedule equivalent to those of a stereotactic radiation treatment

Michael R. Horsman, Thomas R. Wittenborn

Cancer Res (2015) 75 (15_Supplement): 1796.

https://doi.org/10.1158/1538-7445.AM2015-1796

Published: 01 August 2015

View article titled, Abstract 1796: Targeting the microenvironment and vasculature of tumors to improve response to radiation administered using a dose and schedule equivalent to those of a stereotactic radiation treatment

Journal Articles

Abstract 850: Vascular based strategies for enhancing tumour response to radiation administered in a stereotactic schedule

Michael R. Horsman, Thomas Wittenborn

Cancer Res (2014) 74 (19_Supplement): 850.

https://doi.org/10.1158/1538-7445.AM2014-850

Published: 01 October 2014

View article titled, Abstract 850: Vascular based strategies for enhancing tumour response to radiation administered in a stereotactic schedule

Journal Articles

Abstract 1816: Assessment of anti-tumor activity of the cathepsin L inhibitor, KGP94

Thomas R. Wittenborn, Michael Stratford, Mary Lynn Trawick, Kevin G. Pinney, David J. Chaplin, Dietmar W. Siemann, Michael R. Horsman

Cancer Res (2014) 74 (19_Supplement): 1816.

https://doi.org/10.1158/1538-7445.AM2014-1816

Published: 01 October 2014

View article titled, Abstract 1816: Assessment of anti-tumor activity of the cathepsin L inhibitor, KGP94

Journal Articles

The Relationship between Tumor Blood Flow, Angiogenesis, Tumor Hypoxia, and Aerobic Glycolysis

Leif Østergaard, Anna Tietze, Thomas Nielsen, Kim Ryun Drasbek, Kim Mouridsen, Sune Nørhøj Jespersen, Michael R. Horsman

Cancer Res (2013) 73 (18): 5618–5624.

https://doi.org/10.1158/0008-5472.CAN-13-0964

Published: 16 September 2013

View article titled, The Relationship between Tumor Blood Flow, Angiogenesis, Tumor Hypoxia, and Aerobic Glycolysis

Journal Articles

Abstract 4958: AMPK as a target to overcome hypoxia-induced treatment resistance in tumors.

Morten Busk, Brita S. Soerensen, Steen Jakobsen, Bent Honoré, Jens Overgaard, Michael R. Horsman

Cancer Res (2013) 73 (8_Supplement): 4958.

https://doi.org/10.1158/1538-7445.AM2013-4958

Published: 15 April 2013

View article titled, Abstract 4958: AMPK as a target to overcome hypoxia-induced treatment resistance in tumors.

Journal Articles

Abstract 5071: KGP94, a small-molecule cathepsin L inhibitor with antitumor activity.

Thomas Wittenborn, Mary Lynn Trawick, Kevin G. Pinney, David J. Chaplin, Dietmar W. Siemann, Michael R. Horsman

Cancer Res (2013) 73 (8_Supplement): 5071.

https://doi.org/10.1158/1538-7445.AM2013-5071

Published: 15 April 2013

View article titled, Abstract 5071: KGP94, a small-molecule cathepsin L inhibitor with antitumor activity.

Journal Articles

Abstract 1416: Development and initial evaluation of the antitumor activity of a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L

Mary Lynn Trawick, Kevin G. Pinney, David J. Chaplin, Michael R. Horsman, Gustavo E. Chavarria, Wara M. Arispe, G. D. Kishore Kumar

Cancer Res (2011) 71 (8_Supplement): 1416.

https://doi.org/10.1158/1538-7445.AM2011-1416

Published: 15 April 2011

View article titled, Abstract 1416: Development and initial evaluation of the antitumor activity of a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L

Journal Articles

Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies

Michael R. Horsman, Dietmar W. Siemann

Cancer Res (2006) 66 (24): 11520–11539.

https://doi.org/10.1158/0008-5472.CAN-06-2848

Published: 18 December 2006

View article titled, Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies

Journal Articles

Validating the use of CAIX and GLUT1 as endogenous markers for hypoxia in solid tumors

Brita S. Sørensen, Jing Hao, Jens Overgaard, Jan Alsner, Michael R. Horsman

Cancer Res (2005) 65 (9_Supplement): 263.

Published: 01 May 2005

View article titled, Validating the use of CAIX and GLUT1 as endogenous markers for hypoxia in solid tumors

Journal Articles

Effect of Changing Tumor Oxygenation on Glycolytic Metabolism in a Murine C3H Mammary Carcinoma Assessed by in Vivo Nuclear Magnetic Resonance Spectroscopy

Flemming U. Nielsen, Preben Daugaard, Lise Bentzen, Hans Stødkilde-Jørgensen, Jens Overgaard, Michael R. Horsman, Ross J. Maxwell

Cancer Res (2001) 61 (13): 5318–5325.

Published: 01 July 2001

View article titled, Effect of Changing Tumor Oxygenation on Glycolytic Metabolism in a Murine C3H Mammary Carcinoma Assessed by <em>in Vivo</em> Nuclear Magnetic Resonance Spectroscopy

Journal Articles

Preclinical Evaluation of the Fluorinated 2-Nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) Acetamide (SR-4554) as a Probe for the Measurement of Tumor Hypoxia

Eric O. Aboagye, Ross J. Maxwell, Andrew B. Kelson, Michael Tracy, Alexander D. Lewis, Martin A. Graham, Michael R. Horsman, John R. Griffiths, Paul Workman

Cancer Res (1997) 57 (15): 3314–3318.

Published: 01 August 1997

View article titled, Preclinical Evaluation of the Fluorinated 2-Nitroimidazole <em>N</em>-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) Acetamide (SR-4554) as a Probe for the Measurement of Tumor Hypoxia

Journal Articles

Combination of Nicotinamide and Hyperthermia to Eliminate Radioresistant Chronically and Acutely Hypoxic Tumor Cells

Michael R. Horsman, David J. Chaplin, Jens Overgaard

Cancer Res (1990) 50 (23): 7430–7436.

Published: 01 December 1990

View article titled, Combination of Nicotinamide and Hyperthermia to Eliminate Radioresistant Chronically and Acutely Hypoxic Tumor Cells

NARROW

Abstract 2854: The potential of hyperpolarized 13-C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents

Abstract 2001: Preclinical investigation of a 15 gene hypoxia profile in different prostate cancer cell lines

Abstract 4498: Assessing the effects of the small molecule cathepsin L inhibitor, KGP94: combination with radiotherapy and evaluation of antimetastatic potential in vivo

Abstract 1796: Targeting the microenvironment and vasculature of tumors to improve response to radiation administered using a dose and schedule equivalent to those of a stereotactic radiation treatment

Abstract 850: Vascular based strategies for enhancing tumour response to radiation administered in a stereotactic schedule

Abstract 1816: Assessment of anti-tumor activity of the cathepsin L inhibitor, KGP94

The Relationship between Tumor Blood Flow, Angiogenesis, Tumor Hypoxia, and Aerobic Glycolysis

Abstract 4958: AMPK as a target to overcome hypoxia-induced treatment resistance in tumors.

Abstract 5071: KGP94, a small-molecule cathepsin L inhibitor with antitumor activity.

Abstract 1416: Development and initial evaluation of the antitumor activity of a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L

Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies

Validating the use of CAIX and GLUT1 as endogenous markers for hypoxia in solid tumors

Effect of Changing Tumor Oxygenation on Glycolytic Metabolism in a Murine C3H Mammary Carcinoma Assessed by in Vivo Nuclear Magnetic Resonance Spectroscopy

Preclinical Evaluation of the Fluorinated 2-Nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) Acetamide (SR-4554) as a Probe for the Measurement of Tumor Hypoxia

Combination of Nicotinamide and Hyperthermia to Eliminate Radioresistant Chronically and Acutely Hypoxic Tumor Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only